Author n= Study Type Location Reported Outcome
Setlik et al. [10] Perforated cornea (n=22) (Isobutyl-cyanoacrylate) Retrospective case series USA 40.9% healed with adhesive alone. 31.8% needed PK. 27.3% multiple application.
Garg et al.[11] Perforated fungal keratitis (n=66) (Butyl-cyanoacrylate) Retrospective case series India 63.6% infiltrate resolved with scar formation. 37.8% multiple application. 24.2% worsening keratitis. 12.1% successful PK.
Moorthy et al. [12] Perforated herpetic keratitis (n=46) (Butyl- cyanoacrylate) Retrospective case series Australia 57% needed PK. 37% complete healing. 31% multiple application. 4% evisceration.
Kasetsuwan et al. [15] Impending and perforated corneas (n=66) (Ethyl- cyanoacrylate) Retrospective case series Thailand 91% successful. 26% required definitive treatment.
Tan et al. [17] (this study) Mixed Aetiologies of perforated cornea N=45 (Butyl-cyanoacrylate) Retrospective case series Australia 67% successful as definitive and temporising measure. 47% healed with adhesive alone.
Sharma et al. [18] Fibrin (n=19) Cyanoacrylate (n = 22) (Butyl- cyanoacrylate) Randomised controlled clinical trial India Both effective. Fibrin glue healed faster. Fibrin glue induced less cornea vascularisation. Fibrin glue required longer time for adhesive plug formation.
Okabe et al. [19] Corneal (n=2) Bleb leak (n=2) (Octyl-cyanoacrylate) Case series Japan All effective. Several applications required. No adverse clinical effects.
Table 1: Summary of clinical trials involving cyanoacrylate in past 10 years.